[Oesophageal cancer: multidisciplinary approach].
Despite recent progresses, the prognosis of oesophageal cancer is still bad, mostly because of frequent late diagnosis. In early cases, radical surgery alone is able to cure 60-70% of the patients. In locally-advanced cases, on the other hand, surgical results are considerably worse and combined therapies are contemplated. In these cases, neoadjuvant therapy (induction chemotherapy followed by radiotherapy and surgical resection) is often proposed, but without formal proof of superiority. These combined therapies are heavy for the patient and complex for the team. They can only be decided and managed in the frame of intensive multidisciplinary collaboration. Future progresses will come at the same time from larger studies and from the efforts of the medical community towards earlier diagnosis of this disease.
Volonté
F
F
Service de chirurgie viscérale, HUG, Genève 14. francesco.volonte@hcuge.ch
Roth
A
A
Betz
M
M
Huber
O
O
D003131:Combined Modality Therapy; D003663:Decision Trees; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D006801:Humans; D010348:Patient Care Team